Prostate cancer incidence among American Indian and Alaska Native men, US, 1999-2004

Cancer

Volumn 113, Issue 5 SUPPL., 2008, Pages 1203-1212

  Henderson, Jeffrey A ^a   Espey, David K ^b   Jim, Melissa A ^b   German, Robert R ^b   Shaw, Kate M ^b   Hoffman, Richard M ^c  

^a Black Hills Center for American Indian Health   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Alaska Native; American Indian; Cancer; Health disparity; Incidence; Misclassification; National Program of Cancer Registries (NPCR); Prostate cancer; Surveillance, Epidemiology, End Results (SEER); US

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AMERICAN INDIAN; ARTICLE; BEHAVIORAL RISK FACTORS SURVEILLANCE SYSTEM; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; DATA ANALYSIS; ETHNIC DIFFERENCE; HEALTH DISPARITY; HUMAN; INDIAN HEALTH SERVICE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK FACTOR; STATISTICAL ANALYSIS; UNITED STATES; ADENOCARCINOMA; ADULT; AGED; ESKIMO; ETHNOLOGY; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; PROSTATE TUMOR; RACE; REGISTER; STATISTICS;

ADENOCARCINOMA; ADULT; AGED; ALASKA; CONTINENTAL POPULATION GROUPS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INUITS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 53449099957     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23739     Document Type: Article

References (57)

1. Penson DF, Chan JM. Prostate cancer. J Urol. 2007;177:2020-2029.
2. Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361:859-864.
3. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119-2152.
4. Gilliland FD, Key CR. Prostate cancer in American Indians, New Mexico, 1969 to 1994. J Urol. 1998;159:893-897; discussion 897-898.
5. Snyder OB, Kelly JJ, Lanier AP. Prostate cancer in Alaska Native men, 1969-2003. Int J Circumpolar Health. 2006;65:8-17.
6. Espey DK, Wiggins C, Jim MA, Miller BA, Johnson C, Becker TM. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer. 2008; 113(5 suppl):1120-1130.
7. U.S. Cancer Statistics Working Group. United States cancer statistics: 2004 incidence. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007.
8. Fritz A, Percy C, Jack A. International classification of diseases of oncology. Geneva: World Health Organization; 2000.
9. Jim MA, Espey DK, Wiggins C, Cobb N, Wingo PA. Racial Misclassification of American Indians Residing Near IHS Facilities. Poster P-47, Final Program and Abstracts. Presented at the North American Association of Central Cancer Registries Conference, Regina, Saskatchewan, Canada. June 2006.
10. Howe HL, Jamison M, Havener L, Chen VW, Ries L and members of the North American Association of Central Cancer Registries Collaborative Research Work Group. Site-specific Comparison of Summary Stage 1977 and Summary Stage 2000 Coding. North American Association of Central Cancer Registries 2005. Available at: http://www.naaccr.org/filesystem/pdf/EOD_SS_All. Accessed on December 17, 2007.
11. Phillips J. Summary stage: data effects of the changes in 2000. Available at: http://www.naaccr.org/filesystem/pdf/Summary%20Stage%20Report%201-21-04b. pdf 2000. Accessed on December 17, 2007.
12. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program. Statistical resources. U.S. population data 1969-2004. Available at: http://seer.cancer.gov/resources. Accessed on December 17, 2007.
13. Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw K. Surveillance for health behaviors of American Indians and Alaska Natives - findings from the Behavioral Risk Factor Surveillance System, 2000-2006. Cancer. 2008;113(5 suppl): 1131-1141.
14. Mokdad AH, Stroup DF, Giles WH. Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep. 2003;52:1-12.
15. Agency for Healthcare Research and Quality. What's New From the U.S. Preventive Services Task Force: An Overview of Recommendations-Screening for Prostate Cancer. AHRQ Pub. No. APPIP03-0003. Rockville, MD: Agency for Healthcare Research and Quality; 2002. Available at: http://www.ahrq.gov/clinic/ 3rduspstf/prostatescr/prostatwh.htm. Accessed on December 17, 2007.
16. Surveillance Research Program. SEER*Stat software. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2007. Available at: http://www.seer.cancer.gov/seerstat. Accessed on December 17, 2007.
17. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15:547-569.
18. American Cancer Society. Cancer facts & figures 2007. Atlanta, GA: American Cancer Society; 2007.
19. Nutting PA, Freeman WL, Risser DR, et al. Cancer incidence among American Indians and Alaska Natives, 1980 through 1987. Am J Public Health. 1993;83:1589-1598.
20. Paltoo DN, Chu KC. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999. Public Health Rep. 2004;119:443-451.
21. Stanford JL, Stephenson RA, Coyle LM, et al. Prostate cancer trends 1973-1995. NIH Pub. No. 99-4543. Bethesda, MD: Surveillance, Epidemiology, and End Results Program, National Cancer Institute; 1999.
22. Swan J, Edwards BK. Cancer rates among American Indians and Alaska Natives: is there a national perspective. Cancer. 2003;98:1262-1272.
23. Wiggins C, Espey D, Wingo PA, et al. Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008;113(5 suppl):1142-1152.
24. Hernandez J, Thompson IM. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer. 2004;101:894-904.
25. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol. 2007;177:107-112; discussion 112.
26. Candas B, Cusan L, Gomez JL, et al. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Prostate. 2000;45:19-35.
27. Gong Z, Neuhouser ML, Goodman PJ, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006;15:1977-1983.
28. Meyer P, Zuern C, Hermanns N, Haak T. The association between paternal prostate cancer and type 2 diabetes. J Carcinog. 2007;6:14.
29. Tavani A, Gallus S, Bertuzzi M, et al. Diabetes mellitus and the risk of prostate cancer in Italy. Eur Urol. 2005;47:313-317; discussion 317.
30. Gonzalez-Perez A, Garcia Rodriguez LA. Prostate cancer risk among men with diabetes mellitus (Spain). Cancer Causes Control. 2005;16:1055-1058.
31. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2056-2062.
32. Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol. 2006;164:1094-1102.
33. Werny DM, Saraiya M, Gregg EW. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol. 2006;164:978-983.
34. Lee ET, Howard BV, Savage PJ, et al. Diabetes mellitus and impaired glucose tolerance in three American Indian populations aged 45-74 years: the Strong Heart Study. IHS Primary Care Provider. 1995;20:97-109.
35. Lee ET, Howard BV, Go O, et al. Prevalence of undiagnosed diabetes in 3 American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study. Diabetes Care. 2000;23:181-186.
36. Gohdes D. Diabetes in North American Indians and Alaska Natives. In: National Diabetes Data Group, Diabetes in America. 2nd ed. NIH Pub. No. 95-1468, 683-701. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995.
37. Lee ET, Welty TK, Cowan LD, et al. Incidence of diabetes in American Indians of 3 geographic areas: the Strong Heart Study. Diabetes Care. 2002;25:49-54.
38. Mokdad AH, Bowman BA, Engelgau MM, Vinicor F. Diabetes trends among American Indians and Alaska Natives: 1990-1998. Diabetes Care. 2001;24:1508-1509.
39. Calton BA, Chang SC, Wright ME, et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIHAARP Diet and Health Study. Cancer Causes Control. 2007;18:493-503.
40. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990;132:895-901.
41. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-1098.
42. Shegem NS, Alsheek Nasir AM, Batieha AM, El-Shanti H, Ajlouni KM. Effects of short term metformin administration on androgens in diabetic men. Saudi Med J. 2004;25: 75-78.
43. Shegem NS, Nasir AM, Jbour AK, Batieha AM, El-Khateeb MS, Ajlouni KM. Effects of short term metformin administration on androgens in normal men. Saudi Med J. 2002; 23:934-937.
44. Bruun L, Ekberg H, Bjork T, Lilja H, Hoglund P, Christensson A. Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation. J Urol. 2004;171:1432-1435.
45. Espey D, Paisano R, Cobb N. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990-2001. Cancer. 2005;103:1045-1053.
46. Espey DK, Paisano RE, Cobb N, Cancer mortality among American Indians and Alaska Natives: regional differences, 1994-1998. Indian Health Service; 2003.
47. Young TK. Review of research on aboriginal populations in Canada: relevance to their health needs. BMJ. 2003;327: 419-422.
48. Wingo PA, King J, Swan J, et al. Breast cancer incidence among American Indian and Alaska Native Women: US, 1999-2004. Cancer. 2008;113(5 supp):1191-1202.
49. Perdue D, Perkins C, Jackson-Thompson J, et al. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999-2004. Cancer. 2008;113(5 suppl):1179-1190.
50. Canales MK. Connecting to nativeness: the influence of women's American Indian identity on their health-care decisions. Can J Nurs Res. 2004;36:18-44.
51. Canales MK, Rakowski W, Howard A. Traditionality and cancer screening practices among American Indian women in Vermont. Health Care Women Int. 2007;28:155-181.
52. Coe K, Attakai A, Papenfuss M, Giuliano A, Martin L, Nuvayestewa L. Traditionalism and its relationship to disease risk and protective behaviors of women living on the Hopi reservation. Health Care Women Int. 2004;25:391-410.
53. Risendal B, DeZapien J, Fowler B, Papenfuss M, Giuliano A. Pap smear screening among urban Southwestern American Indian women. Prev Med. 1999;29(6 pt 1):510-518.
54. Solomon TG, Gottlieb NH. Measures of American Indian traditionality and its relationship to cervical cancer screening. Health Care Women Int. 1999;20:493-504.
55. Giuliano A, Papenfuss M, de Guernsey de Zapien J, Tilousi S, Nuvayestewa L. Breast cancer screening among southwest American Indian women living on-reservation. Prev Med. 1998;27:135-143.
56. Pearson D, Cheadle A, Wagner E, Tonsberg R, Psaty BM. Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med. 1994;23:461-464.
57. Haverkamp D, Espey DK, Paisano RE, Cobb N. Cancer mortality among American Indians and Alaska Natives: regional differences, 1999-2003. Indian Health Service; 2008.